Search Results
Search for other papers by Charles E Massie in
Google Scholar
PubMed
Search for other papers by Inmaculada Spiteri in
Google Scholar
PubMed
Search for other papers by Helen Ross-Adams in
Google Scholar
PubMed
Search for other papers by Hayley Luxton in
Google Scholar
PubMed
Search for other papers by Jonathan Kay in
Google Scholar
PubMed
Search for other papers by Hayley C Whitaker in
Google Scholar
PubMed
Search for other papers by Mark J Dunning in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by Alastair D Lamb in
Google Scholar
PubMed
Search for other papers by Antonio Ramos-Montoya in
Google Scholar
PubMed
Search for other papers by Daniel S Brewer in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by Colin S Cooper in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by Rosalind Eeles in
Google Scholar
PubMed
Search for other papers by UK Prostate ICGC Group in
Google Scholar
PubMed
Search for other papers by Anne Y Warren in
Google Scholar
PubMed
Search for other papers by Simon Tavaré in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by David E Neal in
Google Scholar
PubMed
Search for other papers by Andy G Lynch in
Google Scholar
PubMed
prostate cancer and AR signalling ( Ramos-Montoya et al . 2014 ). Herein, we characterise an epigenetic alteration at the promoter of the related HES5 gene, which has been recently reported in a panel of genes that showed promise as a prostate cancer
Search for other papers by James Yao in
Google Scholar
PubMed
Search for other papers by Abhishek Garg in
Google Scholar
PubMed
Search for other papers by David Chen in
Google Scholar
PubMed
Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Search for other papers by Paul Engstrom in
Google Scholar
PubMed
Search for other papers by Rodney Pommier in
Google Scholar
PubMed
Search for other papers by Eric Van Cutsem in
Google Scholar
PubMed
Search for other papers by Simron Singh in
Google Scholar
PubMed
Search for other papers by Nicola Fazio in
Google Scholar
PubMed
Search for other papers by Wei He in
Google Scholar
PubMed
Search for other papers by Markus Riester in
Google Scholar
PubMed
Search for other papers by Parul Patel in
Google Scholar
PubMed
Search for other papers by Maurizio Voi in
Google Scholar
PubMed
Search for other papers by Michael Morrissey in
Google Scholar
PubMed
Search for other papers by Marianne Pavel in
Google Scholar
PubMed
Search for other papers by Matthew Helmut Kulke in
Google Scholar
PubMed
Communications 5 3518 . ( https://doi.org/10.1038/ncomms4518 ) 24670920 10.1038/ncomms4518 Frampton GM Fichtenholtz A Otto GA Wang K Downing SR He J Schnall-Levin M White J Sanford EM An P , et al . 2013 Development and validation of a clinical cancer
Search for other papers by Lei Qiao in
Google Scholar
PubMed
Search for other papers by Chao Dong in
Google Scholar
PubMed
Search for other papers by Wenlei Jia in
Google Scholar
PubMed
Search for other papers by Gang Sun in
Google Scholar
PubMed
miRNA is dysregulated in various cancers and plays roles as either oncogenes or tumor suppressors, which are tightly related to tumor development and occurrence ( Calin & Croce 2006 ), as well as chemoresistance ( Ashrafizadeh et al. 2020 a ). Rab5
Search for other papers by Gina Chia-Yi Chu in
Google Scholar
PubMed
Search for other papers by Haiyen E Zhau in
Google Scholar
PubMed
Search for other papers by Ruoxiang Wang in
Google Scholar
PubMed
Uro-Oncology Research, Surgery, Biomedical Sciences, Biostatistics and Bioinformatics Center, Department of Pathology, Department of Pathology, Department of Biochemistry and Cell Biology, Department of Medicine, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, 8750 Beverly Blvd., Atrium 103, Los Angeles, California 90048, USA Departments of
Search for other papers by André Rogatko in
Google Scholar
PubMed
Search for other papers by Xu Feng in
Google Scholar
PubMed
Search for other papers by Majd Zayzafoon in
Google Scholar
PubMed
Search for other papers by Youhua Liu in
Google Scholar
PubMed
Search for other papers by Mary C Farach-Carson in
Google Scholar
PubMed
Uro-Oncology Research, Surgery, Biomedical Sciences, Biostatistics and Bioinformatics Center, Department of Pathology, Department of Pathology, Department of Biochemistry and Cell Biology, Department of Medicine, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, 8750 Beverly Blvd., Atrium 103, Los Angeles, California 90048, USA Departments of
Search for other papers by Sungyong You in
Google Scholar
PubMed
Uro-Oncology Research, Surgery, Biomedical Sciences, Biostatistics and Bioinformatics Center, Department of Pathology, Department of Pathology, Department of Biochemistry and Cell Biology, Department of Medicine, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, 8750 Beverly Blvd., Atrium 103, Los Angeles, California 90048, USA Departments of
Search for other papers by Jayoung Kim in
Google Scholar
PubMed
Uro-Oncology Research, Surgery, Biomedical Sciences, Biostatistics and Bioinformatics Center, Department of Pathology, Department of Pathology, Department of Biochemistry and Cell Biology, Department of Medicine, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, 8750 Beverly Blvd., Atrium 103, Los Angeles, California 90048, USA Departments of
Uro-Oncology Research, Surgery, Biomedical Sciences, Biostatistics and Bioinformatics Center, Department of Pathology, Department of Pathology, Department of Biochemistry and Cell Biology, Department of Medicine, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, 8750 Beverly Blvd., Atrium 103, Los Angeles, California 90048, USA Departments of
Search for other papers by Michael R Freeman in
Google Scholar
PubMed
Uro-Oncology Research, Surgery, Biomedical Sciences, Biostatistics and Bioinformatics Center, Department of Pathology, Department of Pathology, Department of Biochemistry and Cell Biology, Department of Medicine, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, 8750 Beverly Blvd., Atrium 103, Los Angeles, California 90048, USA Departments of
Search for other papers by Leland W K Chung in
Google Scholar
PubMed
established by our laboratory ( Xu et al . 2006 ) represent stages of human PCa progression. They were maintained in T-medium (Invitrogen) supplemented with 5% FBS. LNCaP and LNCaP Neo/RANKL were maintained in RPMI-1640 supplemented with 10% FBS. RAW264
Dan L. Duncan Comprehensive Cancer Center, Houston, Texas, USA
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA
Search for other papers by Salma Kaochar in
Google Scholar
PubMed
Search for other papers by Aleksandra Rusin in
Google Scholar
PubMed
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA
Search for other papers by Christopher Foley in
Google Scholar
PubMed
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA
Search for other papers by Kimal Rajapakshe in
Google Scholar
PubMed
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA
Search for other papers by Matthew Robertson in
Google Scholar
PubMed
Search for other papers by Darlene Skapura in
Google Scholar
PubMed
Search for other papers by Cammy Mason in
Google Scholar
PubMed
Search for other papers by Karen Berman De Ruiz in
Google Scholar
PubMed
Search for other papers by Alexey Mikhailovich Tyryshkin in
Google Scholar
PubMed
Search for other papers by Jenny Deng in
Google Scholar
PubMed
Search for other papers by Jin Na Shin in
Google Scholar
PubMed
Search for other papers by Warren Fiskus in
Google Scholar
PubMed
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA
Search for other papers by Jianrong Dong in
Google Scholar
PubMed
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA
Department of Education, Innovation, and Technology, Baylor College of Medicine, Houston, Texas, USA
Search for other papers by Shixia Huang in
Google Scholar
PubMed
Search for other papers by Nora M Navone in
Google Scholar
PubMed
Search for other papers by Christel M Davis in
Google Scholar
PubMed
Search for other papers by Erik A Ehli in
Google Scholar
PubMed
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA
Search for other papers by Cristian Coarfa in
Google Scholar
PubMed
Dan L. Duncan Comprehensive Cancer Center, Houston, Texas, USA
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA
Search for other papers by Nicholas Mitsiades in
Google Scholar
PubMed
(Biorad). Total protein lysate (40 μg) was loaded into 8.5% polyacrylamide gels or NuPage 4–12% Bis-Tris gels and transferred as previously described ( He et al. 2014 ). Images were acquired using an infrared scanner (Odyssey (LiCoR), Lincoln, NE) and
Search for other papers by K M Biernacka in
Google Scholar
PubMed
Search for other papers by R A Persad in
Google Scholar
PubMed
Search for other papers by A Bahl in
Google Scholar
PubMed
Search for other papers by D Gillatt in
Google Scholar
PubMed
Search for other papers by J M P Holly in
Google Scholar
PubMed
Search for other papers by C M Perks in
Google Scholar
PubMed
( Murtola et al . 2008 , Wright & Stanford 2009 ) and improved survival in prostate cancer patients ( He et al . 2011 ). The anticancer effects of metformin could be mediated by a canonical pathway involving the activation of AMP-activated protein
Division of Environmental Genetics and Molecular Toxicology, Division of Epidemiology and Biostatistics, Center for Environmental Genetics, Cancer Center, Department of Pathology, Department of Pathology and Laboratory Medicine, Department of Environmental Health
Division of Environmental Genetics and Molecular Toxicology, Division of Epidemiology and Biostatistics, Center for Environmental Genetics, Cancer Center, Department of Pathology, Department of Pathology and Laboratory Medicine, Department of Environmental Health
Search for other papers by Yuet-Kin Leung in
Google Scholar
PubMed
Search for other papers by Hung-Ming Lam in
Google Scholar
PubMed
Search for other papers by Shulin Wu in
Google Scholar
PubMed
Search for other papers by Dan Song in
Google Scholar
PubMed
Search for other papers by Linda Levin in
Google Scholar
PubMed
Search for other papers by Liang Cheng in
Google Scholar
PubMed
Search for other papers by Chin-Lee Wu in
Google Scholar
PubMed
Division of Environmental Genetics and Molecular Toxicology, Division of Epidemiology and Biostatistics, Center for Environmental Genetics, Cancer Center, Department of Pathology, Department of Pathology and Laboratory Medicine, Department of Environmental Health
Division of Environmental Genetics and Molecular Toxicology, Division of Epidemiology and Biostatistics, Center for Environmental Genetics, Cancer Center, Department of Pathology, Department of Pathology and Laboratory Medicine, Department of Environmental Health
Search for other papers by Shuk-Mei Ho in
Google Scholar
PubMed
addition to the wild-type ERβ or ERβ1, four spliced variants designated as ERβ2–5 have been identified ( Moore et al . 1998 ). The ERβ2–5 isoforms share the first four functional domains with ERβ1, but each has a unique activation function 2 (AF2) domain
Search for other papers by Kreepa G Kooblall in
Google Scholar
PubMed
Search for other papers by Victoria J Stokes in
Google Scholar
PubMed
Search for other papers by Omair A Shariq in
Google Scholar
PubMed
Search for other papers by Katherine A English in
Google Scholar
PubMed
Search for other papers by Mark Stevenson in
Google Scholar
PubMed
Search for other papers by John Broxholme in
Google Scholar
PubMed
Search for other papers by Benjamin Wright in
Google Scholar
PubMed
Search for other papers by Helen E Lockstone in
Google Scholar
PubMed
Search for other papers by David Buck in
Google Scholar
PubMed
Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed
Search for other papers by Christopher J Yates in
Google Scholar
PubMed
Oxford NIHR Biomedical Research Centre, Oxford University Hospitals Trust, Oxford, UK
Search for other papers by Rajesh V Thakker in
Google Scholar
PubMed
Search for other papers by Kate E Lines in
Google Scholar
PubMed
screening for tumours, from as young as 5 years of age. Current clinical guidelines recommend annual surveillance for tumours by biochemical analyses (e.g. calcium, fasting glucose and hormones such as insulin, gastrin and prolactin) and radiological
Search for other papers by Xiaoli Liu in
Google Scholar
PubMed
Search for other papers by Chunhai Zhang in
Google Scholar
PubMed
Search for other papers by Xiaomiao Wang in
Google Scholar
PubMed
Search for other papers by Can Cui in
Google Scholar
PubMed
Search for other papers by Hanwen Cui in
Google Scholar
PubMed
Search for other papers by Baishu Zhu in
Google Scholar
PubMed
Search for other papers by Anqi Chen in
Google Scholar
PubMed
Search for other papers by Lu Zhang in
Google Scholar
PubMed
Search for other papers by Jingwei Xin in
Google Scholar
PubMed
Search for other papers by Qingfeng Fu in
Google Scholar
PubMed
Division of Surgery, Istituto Auxologico Italiano, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy
Search for other papers by Gianlorenzo Dionigi in
Google Scholar
PubMed
Search for other papers by Hui Sun in
Google Scholar
PubMed
He S Yang Q Guo W Lai Y Du H Peng X 2019 Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-beta signaling . Theranostics 9 6063
David Geffen School of Medicine, University of California – Los Angeles, Los Angeles, California, USA
Search for other papers by Andrew G Gianoukakis in
Google Scholar
PubMed
Search for other papers by Corina E Dutcus in
Google Scholar
PubMed
Search for other papers by Nicolas Batty in
Google Scholar
PubMed
Search for other papers by Matthew Guo in
Google Scholar
PubMed
Search for other papers by Mahadi Baig in
Google Scholar
PubMed
with greater disease burden (tumor size ≤35 mm: 44.3 months; 35–60 mm: 27.5 months; 60–92 mm: 18.0 months; >92 mm: 15.7 months), patients with liver metastasis (yes: 15.7 months; no: 30.5 months) and patients with brain metastasis (yes: 9.3 months; no